Purpose The α 7 nicotinic acetylcholine receptor (nAChR) is implicated in many neuropsychiatric disorders, making it an important target for positron emission tomography (PET) imaging. The first aim of this work was to compare two α 7 nAChRs PET radioligands, [ 
Introduction
The homomeric α 7 subtype of nicotinic acetylcholine receptors (nAChRs) is a class of ligand-gated ion channels distributed throughout the brain [1] . Abnormalities of α 7 nAChRs are implicated in inflammatory processes [2] , schizophrenia [3] , Alzheimer's disease [4] , depression [5] , and substance approaches were compared to identify the optimal analysis method and scan duration for quantification of [
Materials and methods

Radiochemistry
Production of both [ 18 
F]ASEM and [
18 F]DBT-10 was performed as previously described [14] . Briefly, both radiotracers were prepared via radiofluorination of their corresponding nitro precursors in the presence of Kryptofix-222. The crude reaction product was purified by semipreparative HPLC followed by solid-phase extraction. Subsequent formulation in 10 mL normal saline containing 1 mL ethanol followed by filter sterilization afforded the final product solution ready for dispensing and administration. Chemical purity, radiochemical purity, and specific radioactivity were determined by analytical HPLC.
Nonhuman primate imaging
Three Macaca mulatta animals were imaged for this study. These animals were as follows: M1, male, 6 years, 10 kg; M2, female, 15 years, 7 kg; M3, female, 16 years, 8 kg. All procedures followed institutional guidelines and were approved by the Yale University Institutional Animal Care and Use Committee.
Baseline PET scans were acquired with both [ 18 
F]ASEM and [
18 F]DBT-10 for all three subjects for a total of six scans. Three additional blocking scans were acquired with [ 18 F ]ASEM in two animals, following administration of 1.84-3.13 nmol/kg (0.67-1.24 mg/kg) cold ASEM as a 15-min slow bolus starting 15-30 min before radiotracer administration. Finally, two compounds with affinity for nicotinic receptors, nicotine and varenicline (Chantix), were administered prior to PET scanning with [ 18 F] ASEM to assess its binding sensitivity to these compounds. These scans were conducted in two different animals each, with 0.24 mg/kg nicotine and 0.33 mg/kg varenicline, respectively, administered 5-10 min prior to radiotracer injection. Supplementary Table 1 summarizes the nonhuman primate imaging sessions.
Animals were first anesthetized with ketamine hydrochloride (10 mg/kg, i.m.) at least 2 h before PET scanning. Anesthesia was then maintained with 1.5-2.5% isoflurane. One catheter was placed in a saphenous vein for radiotracer administration, while a second catheter was placed in a radial or femoral artery for blood sampling. Vital signs, including respiration rate, heart rate, blood pressure, end tidal CO 2 , SpO 2 , and temperature were continuously monitored for the duration of scanning procedures.
PET data were acquired on a Focus 220 PET scanner (Siemens/CTI, Knoxville, TN, USA), which has an intrinsic resolution of 1.4 mm FWHM at the center of the field of view. Prior to radiotracer administration, a transmission scan was obtained with a rotating 137 Cs source over 9 min. Radiotracer ([ 18 
Human imaging procedures
Six healthy volunteers (five men, one woman; 26-51 years old) were recruited from the local community. Of these six subjects, four subjects returned for a retest scan to examine the test-retest variability of [ 18 F]ASEM quantification. Written informed consent was obtained from all subjects. Subjects were screened for the following criteria: no current or history of major medical illness; no psychotropic drug use in the previous 6 months; no DSM IV Axis I diagnosis for neurological or psychiatric disorders; not pregnant or breastfeeding. Study approval and oversight was administered by the Human Investigation Committee, Yale University School of Medicine, and Yale-New Haven Hospital Radiation Safety Committee, in accordance with the Protection of Human Subjects of Research and Ethical Principle and Guidelines.
PET data were acquired with a High Resolution Research Tomograph (HRRT; Siemens/CTI; Knoxville, TN, USA).
Image data processing and analysis
List-mode PET data were histogrammed into time bins up to 5 min long and reconstructed into imaging space. Nonhuman primate data from the Focus 220 were reconstructed with Fourier rebinning followed by 2-D filtered back projection with a 0.15 mm −1 Shepp filter. Human data from the HRRT were reconstructed with the ordered subsets expectation maximization based MOLAR algorithm, including corrections for observed subject motion [18] . For Focus 220 data, reconstructed PET images were registered to each subject's MR image using a rigid body registration algorithm [19] , and the subject's MR image was subsequently normalized to a rhesus monkey MRI atlas [20] . For HRRT data, the first 10 min of PET data were summed and registered to a subject-specific MR image using a rigid mutual information algorithm (FLIRT, FSL 3.2; Analysis Group; FMRIB, Oxford, UK), and the subject's MR image was subsequently normalized to the AAL template. Both MRI normalization procedures used the nonlinear registration algorithm in BioImage Suite 3.01 (www.bioimagesuite.org/index.html). Binary template masks identifying the caudate, cerebellum, cingulate cortex, frontal cortex, hippocampus, occipital cortex, pons, putamen, temporal cortex, and thalamus were used to extract timeactivity curves from these regions. For all scans, the primary outcome measure was total distribution volume (V T ) [21] . Free-fraction corrected total distribution volumes (V T /f P ) were also recorded. These values were administered as a slow bolus controlled by a syringe pump (PHD 22/2000, Harvard Apparatus, Holliston, MA, USA). List-mode PET data were continuously acquired for up to 240 min. Discrete arterial blood samples were manually acquired and analyzed to measure the parent input function, as described in Supplement B, consistent with previous procedures [14] . Additionally, the free fraction (f P ) in plasma was measured with ultrafiltration cartridges (Millipore Centifree UF devices) in triplicate for each scan. The baseline [ 18 F]DBT-10 scans were previously reported [14] . To assess the specific binding of the radiotracer [ 18 F]ASEM, blocking scans using cold doses of ASEM were acquired. Additional studies using pre-blocking doses of nicotine and varenicline were conducted due to the importance of these compounds in substance use disorders, particularly tobacco smoking. Nicotine binds to α 4 β 2 nAChRs with high affinity (K i = 0.95 nM), but has low affinity for α 7 nAChRs (K i = 6290 nM) [16] . Varenicline is a partial agonist for α 4 β 2 nAChRs (K i = 0.06 nM) and full agonist at α 7 nAChRs (K i = 322 nM) with efficacy for smoking cessation [16, 17] . A table summarizing the radiotracers, blocking drug doses, and animals imaged for the blocking scans is displayed in Supplementary Table 1. A high-resolution T1-weighted MR image was also acquired with a Siemens 3 T Trio scanner for each subject. An extremity coil was used to acquire data in the coronal direction with a spin echo sequence as follows: Cs transmission scan acquired afterwards. Blood samples were manually acquired from a radial artery to measure the metabolitecorrected arterial input function and analyzed using the same methods as in nonhuman primate experiments described above [14] and in Supplement B.
High-resolution T1-weighted MR images were acquired with a 3 T Trio MR scanner (Siemens Medical Systems, Erlangen, Germany) for each human subject prior to PET sessions. The weighted gradient-echo (MPRAGE) sequence included TE = 3.3 ms; TI = 1100 ms; TF = 2500 ms; FA = 7°, resulting in a 1 mm 3 isotropic resolution. Non-brain structures were removed from the image using FMRIB's Brain Extraction Tool.
calculated in all regions with the one-tissue (1TCM) and twotissue (2TCM) compartment models [22] and multilinear analysis method (MA1) [23] . The MA1 operational equation is:
where C T is the radioactivity concentration in the tissue and C P is the parent radiotracer concentration in arterial plasma. Analyses were performed with in-house code developed in IDL. To compare model suitability, an Akaike information criterion (AIC; [24] ) value was calculated for each model fit in every region. Values within each region were compared across models, and the lowest AIC value indicated a preferred model fit. MA1 was also used to estimate V T at the voxel level to create parameterized maps for visual assessment. For the blocking scans in nonhuman primates, Lassen plots were used to estimate receptor occupancy and V ND values [25] .
The test-retest reproducibility of the primary outcome measure, V T , was evaluated in each region for the four human subjects with repeated PET scans. 
Results
Nonhuman primate imaging
Radiotracers were produced with high radiochemical purity (>99%) and high specific activity at time of injection (418 ± 362 GBq/μmol for [ 18 The time courses of both radiotracers in the nonhuman primate brain were similar, as shown in Fig. 3 . Kinetic analysis with compartment modeling identified the 2TCM as a better model than 1TCM for both radiotracers due to lower AIC scores across all regions. The K 1 values were high for both radiotracers, with averages of 0.59 ± 0.14 mL/cm Fig. 3c ). (Fig. 4c) . The 1TCM was well suited for [ 18 Supplementary Figure 3) . Values of AIC for 1TCM were lower or equivalent compared to those obtained with the 2TCM (see Supplementary Table 2) , and kinetic modeling of the data with 2TCM did not converge to reliable V T estimates in hippocampus for all subjects. V T values ranged from 20.0 ± 3.2 mL/cm 3 in cerebellum to 26.6 ± 3.3 mL/cm 3 in thalamus, while K 1 values ranged from 0.26 ± 0.04 mL/cm 3 per min in hippocampus to 0.39 ± 0.10 mL/cm 3 per min in putamen, as shown in Table 1 . Use of MA1 with t* = 30 min yielded comparable V T values with 1TCM (V T(MA1) = 1.02V T(1TCM) + 0.01; R 2 = 0.995; see Supplementary Figure 4) , as demonstrated in Table 1 . Sample MA1 fits are shown in Fig. 4c . To explore the effects of scan duration, the 180 min of data were truncated to 120 min, 90 min, and 60 min, and V T values were compared. Shorter data durations negatively biased V T and increased parameter variability. Using 120 min of data underestimated V T values by 4.2 ± 2.6% (R 2 = 0.948; Supplemental Figure 5A ); using 90 min of data underestimated V T by 5.5 ± 3.8% (R 2 = 0.878; SuppFig. 5B); using 60 min of data underestimated V T by 7.4 ± 5.1 (R 2 = 0.715; SuppFig. 5C). Based on the reduced consistency of V T estimation with 60 min of data (R 2 = 0.715), at least 90 min of PET data are recommended for accurate [ 18 
F]ASEM quantification (see sample fit shown in
F]ASEM V T quantification.
Of the six subjects scanned, four returned 7-10 days later for a retest scan. Based on V T values estimated with MA1 using 120 min of acquired PET data, test-retest variation of
Discussion
This work directly compares the in vivo kinetic properties of two PET radiotracers specific to α 7 nAChRs, [ 18 
F]ASEM and [
18 F]DBT-10, in nonhuman primates. Although the two radiotracers were highly similar, we selected [ 18 F]ASEM for translation to human studies, as its use in humans has been reported previously [11] . That report indicated the need for further confirmation of [ 18 F]ASEM test-retest variability due to the limited number of subjects in their first-in-human study [11] . This second characterization of [ Fig. 1 ). In contrast to initial in vitro binding results [12] , further in vitro data indicated that [ 18 V T was 11.7 ± 9.8%. The plasma-free fraction (f P ) exhibited a test-retest variation of −5.3 ± 18.0%, and the test-retest variation of V T /f P was 9.3 ± 7.3%. These data are summarized in Table 1 . A set of V T parametric images from the test and retest scans in a representative subject are shown in Fig. 5 . [14] . In this study we acquired baseline PET scans in the same rhesus monkeys for a direct quantitative comparison. Compartment modeling results indicated no differences in K 1 and k 2 parameters between the radiotracers. Guo plots [26] were then used to directly compare specific binding and in vivo affinities of the radiotracers. The yintercept of Guo plots is related to the ratio of binding potentials (BP ND ), and the estimated intercepts of nearly zero indicated equivalent BP ND values for the two radiotracers. The slope of Guo plots is proportional to the ratio of in vivo K D values, and the estimated values suggested similar in vivo K D values for the two radiotracers. Further technical considerations for analysis with the Guo plots are discussed in Supplement C. Anesthesia effects likely did not influence these studies because the same anesthesia protocol was used for the same animals, and evidence for no effects of either ketamine or isoflurane on α 7 nAChRs has been reported previously [33, 34] . Taken together, the experimental data indicate that [ 18 [35] at concentrations found in cigarette smokers, and nicotine's affinity for α 7 nAChRs is two to three orders of magnitude lower than that for α 4 β 2 nAChRs [16, 36] .
Blocking studies with a second nicotinic compound, varenicline (Chantix), were performed to assess the sensitivity of [ 18 F]ASEM specific binding to this drug, which has therapeutic efficacy for smoking cessation [37] . A dose of 0.33 mg/ kg varenicline, estimated as roughly twice the therapeutic dose [38] , resulted in no significant effects on [ 18 F]ASEM V T . While varenicline has an order of magnitude higher affinity for α 7 nAChRs than nicotine [16] , its affinity is still roughly three orders of magnitude lower than that of ASEM [9] , and therapeutic doses of varenicline are not expected to induce functional effects on α 7 nAChRs [38] . Thus, the data suggesting no competition of 0.33 mg/kg varenicline with [ 18 F]ASEM are not unexpected. Notably, previous work described blocking of [ 18 F] ASEM uptake with 0.18 mg/kg varenicline in mice [11] . However, this work reported activity levels as % injected dose/g of tissue, which does not take into account changes in radioligand delivered to tissue from the arterial plasma under the blocking conditions. Indeed, our data indicate that varenicline administration reduced the parent [ 18 Figure 2B) . Previous studies suggested that cold ASEM administration increased [ 18 F]DBT-10 f P [14] ; however, insufficient blood data were acquired after drug administration in the present work to assess their effects on [ 18 F]ASEM f P . Therefore, we report V T here as the primary outcome measure.
PET imaging of α 7 nAChRs with [ 18 F]ASEM in healthy humans was conducted with the goal of validating the optimal experimental and analysis procedures. In our hands, the parent fraction, input function, and tissue activity curves of [ 18 F]ASEM were similar to those from the first report of [ 18 F]ASEM PET imaging in humans, while values of V T estimated here appear to be roughly 15% higher than those previously reported [11] . However, that initial report only acquired 90 min of PET scan data, while here we acquired PET data for up to 180 min post-injection.
The MA1 analysis method with at least 90 min of data was selected for V T estimation. With our data, 2TCM did not converge to reliable parameter estimates in regions such as the hippocampus where washout of radioactivity in tissue was slower than other regions (see Fig. 4c ). Further, AIC values for 1TCM were lower or equivalent to 2TCM in almost all cases (see Supplementary Table 2 ), indicating that 1TCM more appropriately quantified [ 18 F]ASEM kinetic parameters than 2TCM. However, structure was present in 1TCM fit residuals for areas of high uptake such as temporal or occipital cortex in some scans, indicating that the 1TCM might produce a biased result in these regions. Therefore, use of MA1 was further investigated as an alternative approach for V T estimation across all regions. MA1 analysis produced good fits to the data and V T values highly consistent with 1TCM results (see Supplementary Figure 4) , suggesting a minimal bias from 1TCM. While 1TCM may be suitable for [ The test-retest variability of V T with this method was 11.7 ± 9.8% in four subjects, which is very similar to the 10.8 ± 5.1% test-retest variability in two subjects reported in the initial [ 18 F]ASEM human study [11] .
In conclusion, this work directly compared the α 7 nAChRspecific radiotracers [ 
